1.
Vopr Onkol
; 57(5): 567-77, 2011.
Artículo
en Ruso
| MEDLINE
| ID: mdl-22238925
Asunto(s)
Antineoplásicos Hormonales/uso terapéutico , Biomarcadores de Tumor/análisis , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias Hormono-Dependientes/tratamiento farmacológico , Receptores de Estrógenos/análisis , Receptores de Progesterona/análisis , Inhibidores de la Aromatasa/uso terapéutico , Neoplasias de la Mama/química , Quimioterapia Adyuvante , Esquema de Medicación , Femenino , Humanos , Neoplasias Hormono-Dependientes/química , Premenopausia , Tamoxifeno/uso terapéutico , Resultado del Tratamiento
2.
Vopr Onkol
; 57(5): 636-40, 2011.
Artículo
en Ruso
| MEDLINE
| ID: mdl-22238935
RESUMEN
Nanobiotechnology, defined as an arm of a nano-system is a rapidly developing area of medicine. Nanomaterials ranging from 1 to 1000 nm in size offer unique advantages of interaction with biological systems on the molecular level. Nanobiotechnologies can be used in definition, diagnosis and treatment of cancer thus leading to the new development of a new discipline--nanooncology. The potential of nanoparticles to be used in in-vivo tumor visualization, biomolecular profiling of tumor growth factors and targeted drug delivery is being studied. These methods stemming from nanotechnology may soon find a broad application in oncology.